awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38602769-328FC460-294C-4280-BEBD-D8F7820641F2
Q38602769-328FC460-294C-4280-BEBD-D8F7820641F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38602769-328FC460-294C-4280-BEBD-D8F7820641F2
GLP-1 Receptor Agonists: Practical Considerations for Clinical Practice.
P2860
Q38602769-328FC460-294C-4280-BEBD-D8F7820641F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38602769-328FC460-294C-4280-BEBD-D8F7820641F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38ea9371e8284d7f561910a5d03d8fbedccf3dfc
P2860
Safety and efficacy of once-weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes over 84 weeks.